Earnings Call · Q4 FY2022·2023-03-06

Q4 22EPS +13.79%·Rev n/aQ3 22EPS -2.08%·Rev n/aQ2 22EPS +15.38%·Rev n/aQ1 22EPS -11.36%·Rev n/a⚠ consensus missing

Immuneering Corp IMRX

Laurence Watts — Unknown

Benjamin Zeskind — Chief Executive Officer

Brett Hall — Chief Scientific Officer

Scott Barrett — Chief Medical Officer

Mallory Morales — Vice President of Finance and Treasurer

+6.2%1d on move date+7.7% vs SPY3d+37.6%5d+54.1%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more IMRX calls or request research access.

More IMRX calls Browse calls Request research access